<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

6xfn

Research datakeyboard_double_arrow_right Bioentity 15 Jun 2020Funded by:NIH | Novel Translational Contr..., NIH | Drug target validation of..., NIH | High Throughput Screening... +2 projects

Authors: M. Sacco; C. Ma; J. Wang; Y. Chen;

6xfn

- Summary
- Related research
  (13)
- Metrics

tips_and_updates
Recommended

No summary information available

Filter by relation

All relations

arrow_drop_down

13 Research products, page 1 of 2

chevron_left
1
2
chevron_right

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average

6xfn

6xfn

13 Research products, page 1 of 2

Crystallographic models of SARS-CoV-2 3CL^pro: in-depth assessment of structure quality and validation

Co-crystallization and structure determination: An effective direction for anti-SARS-CoV-2 drug discovery

Biflavonoid as potential 3-chymotrypsin-like protease (3CLpro) inhibitor of SARS-Coronavirus

Microsecond MD Simulation and Multiple-Conformation Virtual Screening to Identify Potential Anti-COVID-19 Inhibitors Against SARS-CoV-2 Main Protease

Synthesis of novel indolo[3,2-c]isoquinoline derivatives bearing pyrimidine, piperazine rings and their biological evaluation and docking studies against COVID-19 virus main protease

Computational molecular docking and virtual screening revealed promising SARS-CoV-2 drugs

Protein structural heterogeneity: A hypothesis for the basis of proteolytic recognition by the main protease of SARS-CoV and SARS-CoV-2

DINC-COVID: A webserver for ensemble docking with flexible SARS-CoV-2 proteins

Structure and inhibition of the SARS-CoV-2 main protease reveals strategy for developing dual inhibitors against M^proand cathepsin L

Structure and inhibition of the SARS-CoV-2 main protease reveals strategy for developing dual inhibitors against M^proand cathepsin L